Trump Admin Announces Deal on Drug Prices: 4 Things to Know
President Donald Trump on Thursday unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy, along with insulin, migraine, and diabetes drugs. The weight loss drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that […]
Weights may beat running for preventing diabetes
Running may help burn calories, but when it comes to preventing diabetes and obesity, pumping iron might have the edge, according to preclinical findings. The research in the Journal of Sport and Health Science compared the effects of endurance and resistance exercise in mice fed a high-fat diet, a widely used model of obesity, hyperglycemia, […]
No Swords, No Subsidies: Let the Market Set Drug Prices
Jeffrey A. Singer On November 6, President Donald Trump announced that the government will refrain from tariffs on Eli Lilly’s and Novo Nordisk’s imported products and active pharmaceutical ingredients and that Medicare and Medicaid will subsidize the use of their drugs. In exchange, the pharmaceutical companies will significantly cut prices for their GLP‑1 weight-loss medications, […]
Thursday links: heavy tech exposure
Markets Are we late in the technology megatrend? (awealthofcommonsense.com) A look at how 2025’s stock market stacks up. (carsongroup.com) Apple Apple ($AAPL) has teamed with Google Gemini to power Siri. (spyglass.org) Why Apple ($AAPL) likely chose to work with Google. (daringfireball.net) Amazon The Amazonification of Whole Foods is accelerating. (wsj.com) Amazon ($AMZN) continues to experiment […]
Trump Cuts Prices on Ozempic and Wegovy in Deal With GLP-1 Weight Loss Drug Makers
President Trump’s plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular GLP-1 weight loss drugs.
Trump Cuts Prices on Ozempic and Wegovy in Deal With GLP-1 Weight Loss Drug Makers
President Trump’s plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular GLP-1 weight loss drugs.
Melodrama at the FDA and the Pfizer-Novo bidding war
On this week’s episode of “The Readout LOUD”: “Mean Girls” melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk bidding war for Metsera. On a jam-packed show, your co-hosts, minus the vacationing Allison DeAngelis, chat with STAT’s D.C. correspondent Lizzy Lawrence about a slow-boiling feud between Vinay Prasad, the head […]
Trump Unveils Historic Drug Price Cuts: Ozempic and Wegovy Reduced to $350 via TrumpRx
What You Should Know: – President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk. – The initiative delivers historic price reductions on some of the world’s most popular drugs, impacting millions of Americans struggling […]
Trump unveils deal to expand coverage and lower costs on obesity drugs
WASHINGTON — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years. But […]
Trump announces deal with Novo Nordisk and Eli Lilly
President Donald Trump announces an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their GLP-1 weight loss drugs Wegovy and Zepbound, a move that could make them more affordable for millions of people.